Advertisement

We need your help now

Support from readers like you keeps The Journal open.

You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.

If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.

Press Association Images
Cork

Result! 130 jobs saved as Pfizer decides not to close Cork factory

Great stuff.

PFIZER HAS REVERSED a decision to close its manufacturing plant in Little Island, securing about 130 jobs.

The company said the Cork facility has grown again in importance due to strong sales of Lipitor (atorvastatin), the cholesterol-lowering medication made there.

A statement also cited the operation’s “demonstrated commitment and continued excellence” as drivers for the decision to keep it open.

The good news comes almost two years after Pfizer announced plans to consolidate its manufacturing operations in Ireland, which included an exit from Little Island.

“At that time we expected to be fully out of Little Island by August of 2014,” the pharma giant said today. “In mid-2014, due to an unexpected increase in atorvastatin demand, the initial Little Island facility exit was revised to the third quarter of 2015.”

“The Little Island site has continued to demonstrate the highest levels of performance, flexibility and commitment to the work we are doing here and I am proud of what has been achieved,” added Seamus Fives, the site leader in Little Island and Ringaskiddy.

The plaudits do come with a warning, however, as supply need reviews will continue into the future.

Earlier: Looking for a job? Munster is the place to be

Today: What have Enda and co achieved in the last four years?

More: Good news on the jobs front: 300 new jobs are heading to Limerick 

Your Voice
Readers Comments
16
    Submit a report
    Please help us understand how this comment violates our community guidelines.
    Thank you for the feedback
    Your feedback has been sent to our team for review.